MyAverix Finance
US · Healthcare
Sorrento Therape (SRNE)
Biotechnology
Sorrento Therape (SRNE) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SRNE
Sorrento Therape (SRNE) — FAQ
What is SRNE's P/E ratio?
The price-to-earnings (P/E) ratio for Sorrento Therape (SRNE) is 25.00 (data as of 2026-05-23).
Does Sorrento Therape pay a dividend?
Dividend yield is not available in the current snapshot for Sorrento Therape (SRNE). Check the MyAverix Finance app for the latest dividend data.
What sector is Sorrento Therape in?
Sorrento Therape (SRNE) is classified in the Healthcare sector (Biotechnology industry).
What exchange is SRNE listed on?
SRNE is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.